CompletedNot applicableNCT00839202

Activity and Content of Factor VIII (FVIII) in Human Plasma: The Assessment of a Novel Immunoassay

Studying Hemophilia

Last synced from ClinicalTrials.gov May 10, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Children's Hospital Los Angeles
Principal Investigator: Edward D Gomperts, MD
Children's Hospital Los Angeles
Intervention: FVIII immuno-assay(other)
Enrollment: 7 enrolled
Eligibility: 18 years · MALE
Timeline: 2006 – 2009

Study locations (1)

Department of Biochemistry University of Vermont, Burlington, Vermont, United States

Collaborators

University of Vermont

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00839202 on ClinicalTrials.gov

Other trials for Hemophilia

Additional recruiting or active studies for the same condition.

See all trials for Hemophilia →

← Back to all trials